Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text










Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Blog
Transformative Antibody Technology Brings Speed and Flexibility to Bioanalytical Assay Development
September 13, 2021
Sponsored by:
Sponsor
Read blog
Antibodies
In Vitro Assays
Chemistry, Manufacturing & Controls
Bio-Rad

Blog
Cutting Edge Conversations: The Role of In Vivo Studies in Personalized Medicine
September 2, 2021
Read blog
Biomarkers
Disease Models
Pharmacology
No items found.
Market Access
No items found.
Biomarkers
HBS
Discovery Life Sciences
Protein Sciences
Antibodies
In Vitro Assays
R&D Systems
Health Economics & Outcomes Research (HEOR)
No items found.

Blog
Looking for Ways to Streamline Your Cell-Based Assays Using Fresh or Frozen Leukopaks?
July 27, 2021
Read blog
Cell Culture & Characterization
Pharmacology
No items found.

Blog
How Preclinical Quality Certifications Help Foster Biopharma-CRO Partnerships [Webinar]
July 2, 2021
Read blog
Biomarkers
Disease Models
No items found.
Biomarkers
Cerba Research

Blog
Generating Evidence for Optimal Market Access: An Executive Interview with Jeff Anderson and Rosemary Jose, OPEN Health
June 15, 2021
Sponsored by:
Sponsor
Read blog
Market Access
OPEN Health

Blog
Discovery's Global Tissue Biomarker Services: A New Offering to Advance Precision Oncology Programs With Biospecimen Solutions, Biomarker Testing and Pathologist Training Services
June 15, 2021
Sponsored by:
Sponsor
Read blog
Biomarkers
HBS
Discovery Life Sciences
Biomarkers
HBS
LifeNet Health LifeSciences
Disease Models
Mariana J Kaplan
No items found.
American Physiological Society
Autoimmune Association
Disease Models
Instrumentation & Products
Satish R. Raj
Nasia Sheikh
Finapres Medical Systems
No items found.
Chemical & Compound Analysis
Björn Heitmann
Barbara Czarniecki
Bruker Corporation
No items found.
Disease Models
Jonas Treebak
Alexander Bartelt
Sable Systems International Inc.
No items found.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Michael Broder
Jesse Ortendahl
PHAR
HealthEconomics.com
Disease Models
Sue Bodine
Aurora Scientific, Inc.
American Physiological Society
Alliance for Aging Research
Disease Models
Paul Marvar
Benjamin Turley
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Market Access
Medical Communications
Health Economics & Outcomes Research (HEOR)
Steven Fountain
Sonya Snedecor
Sajjad Raza
PRECISIONheor
OPEN Health
PRMA Consulting
Scientist.com
Market Access
Medical Communications
Sajjad Raza
Steven Fountain
Sonya Snedecor
OPEN Health
PRECISIONheor
PRMA Consulting
Scientist.com
Disease Models
Stefano Gaburro
Brun Ulfhake
Tecniplast S.p.A.
American Physiological Society
Alliance for Aging Research
Disease Models
Aileen King
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Cell Culture & Characterization
Pharmacology
Toxicology
Daniel Merriman
Femi Egbebi
Krzysztof Inglot
Thermo Fisher Scientific
No items found.
Pharmacology
Jonathan Nakashima
Grace Walton
Certis Oncology Solutions, Inc.
Hera BioLabs
Scientist.com

Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)

Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)

Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.

Whitepaper
Insights from Spatial Biology in Drug Discovery at IRBM: The Impact of Cellular Ecosystems
July 28, 2026
Sponsored by:
Sponsor
Access now
Bioimaging
Biomarkers
DNA & RNA
Protein Sciences
Disease Models
IRBM

Whitepaper
Direct to Biology: An Approach to Streamline the DMTA Cycle in PROTAC Discovery
July 7, 2026
Sponsored by:
Sponsor
Access now
Protein Sciences
Pharmacology
In Vitro Assays
DMPK
Concept Life Sciences




























.avif)






